Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Zim Laboratories Ltd - 541400 - Announcement under Regulation 30 (LODR)-Meeting Updates

 Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors on 06th June, 2022 have approved the issuance of Notice convening an Extra-ordinary General Meeting ('EGM') of the members of the Company to be held on Wednesday, 29th June, 2022 at 12:30 p.m. through Video Conferencing / Other Audio Visual Means, to seek approval of the members of the Company in respect of the proposed appointments/reappointments of the Directors.
06-06-2022
Bigul

Zim Laboratories Ltd - 541400 - Disclosure Under Regulation 23(9) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015.

 In compliance with Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, enclosed is the disclosure of Related Party Transactions for the half year ended March 31, 2022.
04-06-2022
Bigul

Zim Laboratories Ltd - 541400 - Corporate Presentation - June 2022

 Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, kindly find enclosed Corporate Presentation - June 2022.
03-06-2022
Bigul

Zim Laboratories Ltd - 541400 - Compliances-Reg.24(A)-Annual Secretarial Compliance

 In terms of SEBI Circular No. CIR/CFD/CMD1/27/2019 dated February 8, 2019, and Pursuant to Regulation 24A of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations 2015, please find enclosed herewith an Annual Secretarial Compliance Report for the financial year ended March 31, 2022 issued by Ms. Yuti Nagarkar, Practicing Company Secretary.
30-05-2022
Bigul

Zim Laboratories Ltd - 541400 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate

 As per the Regulation 39(3) of SEBI (Listing Obligations and Disclosure Requirement), Regulation 2015, RTA have received request from the shareholder for issue of Duplicate Share Certificates and accordingly, RTA of the Company has marked stop transfer until Duplicate Share Certificates are issued.
27-05-2022
Bigul

Zim Laboratories Ltd - 541400 - Announcement under Regulation 30 (LODR)-Newspaper Publication

 Pursuant to Regulation 47 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find enclosed copies of Newspaper Publication regarding Financial Results for the quarter and year ended as on 31.03.2022, published on 22.05.2022 in the following newspapers :- 1) Financial Express (English) 2) Indian Express (English) 3) Loksatta (Marathi) Kindly take the intimation on record.
23-05-2022
Bigul

Zim Laboratories Ltd - 541400 - Board Meeting Outcome for Outcome Of Board Meeting And Disclosure Under Regulation 30 Of SEBI (LODR) Regulations, 2015 - Reappointment Of Directors

 This is to inform you that the Board of Directors in their meeting held on 21st May, 2022 considered and approved the following : 1.Audited Financial Statements (Standalone and Consolidated) of the Company for the year ended 31st March, 2022. 2.Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended 31st March, 2022 (prepared pursuant to SEBI (LODR) Regulations, 2015).Walker Chandiok & Co LLP, Chartered Accountants, the Statutory Auditors of the Company have issued auditor''s report with an unmodified opinion on the financial results for the year ended 31st March, 2022 which is enclosed herewith.
21-05-2022
Bigul

Annual report for Zim Laboratories Ltd. for FY-2022
21-05-2022
Bigul

Zim Laboratories Ltd - 541400 - Board Meeting Intimation for Intimation Under Regulation 29 Of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015.

 Zim Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 21/05/2022 ,inter alia, to consider and approve a) Audited Financial Statements (Standalone and Consolidated) of the Company for the year ended 31st March, 2022. b)Financial Results (Standalone and Consolidated) of the Company for the quarter and year ended 31st March, 2022 (prepared pursuant to Regulation 33 of SEBI (LODR) Regulations, 2015).
14-05-2022
Bigul

Zim Laboratories Ltd - 541400 - Press Release For Grant Of Marketing Authorization For Sildenafil Citrate 50 Mg Orally Dissolving Film In Spain, Europe.

 Please find enclosed herewith our Press Release relating to grant of Marketing Authorization for Sildenafil Citrate 50 mg Orally dissolving film in Spain, Europe to Wholly-owned European Subsidiary of the company.
12-05-2022
Next Page
Close

Let's Open Free Demat Account